Cleveland Clinic Foundation
Cleveland, Ohio, 44195, United States
Location status: Recruiting
Location contact
Annette Bellar, BS
CONTACT
Revathi Penumatsa
CONTACT
Srinivasan Dasarathy, MD
PRINCIPAL_INVESTIGATOR
NCT Number: NCT04088370
Inflammatory responses in response to alcohol have been identified as contributing to the development of alcoholic hepatitis. The inflammatory response including that to LippoPolySaccharide is known to lead to progression of alcoholic liver disease. In addition to the inflammatory response mitochondrial perturbations exist and redox homeostasis is altered in patients with alcoholic hepatitis. Though this is known there have been very few studies targeting mitochondrial function in Peripheral Blood Mononuclear Cells (PBMCs). We plan to collect 50 milliliters of blood from healthy control patients so that we can compare the data to that of patients with alcoholic hepatitis and those who are heavy drinkers without liver disease. In addition to studying mitochondrial function we will investigate cytokine response, as well as fatty acid metabolism, glucose, and insulin measurements
Interested in participating?
Request Info21 year–65 year
All sexes
Observational
Cleveland, Ohio, 44195, United States
Location status: Recruiting
Annette Bellar, BS
CONTACT
Revathi Penumatsa
CONTACT
Srinivasan Dasarathy, MD
PRINCIPAL_INVESTIGATOR
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion of Subjects with Alcoholic Hepatitis (AH):
*diagnosis of AH either by imaging, biochemical values or liver biopsy as well as drinking history
Inclusion Heavy Drinking Controls:
*heavy alcohol drinking will be defined as >40 g/day or >280g/week on average for women and >60 g/day or >420 g/week on average for men for a minimum of 6 months [6] and within the 4 weeks prior to study enrollment.
Exclusion criteria
for all groups
Control subjects (drinking and non drinking) must meet the following criteria:
Blood Draw Only
Time frame: 1 day
Mitochondrial Respiration will be quantified by using a standard substrate, uncoupler, inhibitor titration protocol using high resolution respirometry
Contact information is provided by the study sponsor or research team.
The Cleveland Clinic
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03845205
Alcohol Use Disorder, Alcohol-Induced Disorders
Baltimore, Maryland, United States
View Trial DetailsNCT06956482
Alcohol-Induced Disorders, Alcohol-Related Disorders
Lille, France
View Trial DetailsNCT06307964
Alcohol-Induced Disorders, Alcohol-Related Disorders
Lyon, France
View Trial DetailsNCT05294744
Alcohol-Induced Disorders, Alcohol-Related Disorders
Vitoria-Gasteiz, Álava, Spain
View Trial Details